Our team of scientists & engineers work together to develop novel engineered materials. These materials have applications in many technological areas including the following:
InnoSense is a uniquely driven engineering company. We are committed to producing technologies for tomorrow, today. Our mission is simple: use our scientific expertise and spirit of innovation to solve problems and improve the way people do things in the U.S., around the world, and in space. Our research staff comprises experts in aerogels, ceramic and glass science, nanotechnology, medical devices and more. Our research and development efforts focus on sensors, materials, coatings, renewable energy and medical diagnostic devices and therapeutic agents. For over 10 years, InnoSense has been developing and commercializing solutions to real world problems.
Uma Sampathkumaran (Vice President of R&D) will attend the 2017 National Armaments Consortium (NAC) General Membership Meeting to be held on March 21-23, 2017 at the Hilton Parsippany, NJ. The NAC General Membership Meeting is a unique opportunity to discuss the requirements, challenges, and emerging opportunities. As a current DOD contractor, ISL will present its current relevant efforts and accomplishments including: Therm-E-Log, a time-temperature dosimeter to monitor the thermal history of ordnance; HyperGoLeak, a hypergolic propellant leak detector; FogGo, durable and abrasion-reistant anti-fog coatings being developed for the Joint Service Aircrew Mask-Fixed Wing Variant (JSAM-FW) lenses.
If you are attending the 2017 NAC General Membership Meeting and are interested in any of our technologies and would like to meet us there, please contact us at email@example.com.
Uma Sampathkumaran (Vice President of R&D), Anamika Ray (Senior Scientist) and Lexi Donne (Technology Transition Consultant) attended the 24th International Molecular Med Tri-Con held in Moscone North Convention Center, San Francisco, CA. ISL representatives took this opportunity to network with organizations in the medical diagnostics market, including current collaborator, Dr. Paul Slowey of Oasis Diagnostics. ISL and Oasis Diagnostics are actively working on the development of a saliva-based Point of Care diagnostic for the detection of multi-organ injuries funded by the Defense Health Agency. Additionally, ISL is actively pursuing development of Point of Care diagnostics for Alzheimer's, mercury poisoning, and Dengue and Chikungunya viruses using our proprietary nanowire platform. To find out more about our diagnostic sensors visit webpage here or please contact us.
The National Institutes of Health has awarded InnoSense a Phase II grant for the work titled "Nanowire Sensor Array-based Assay for Early Diagnosis of Alzheimer's Disease." This project is a continuation of the Phase I grant. During Phase I, ISL successfully demonstrated that the biosensor is capable of detecting 100 femtomolar level Alzheimer's Disease specific biomarkers. In Phase II, ISL will further optimize and evaluate the biosensor's performance.
Uma Sampathkumaran, Vice President of R&D and May Maung, Research Engineer, will represent InnoSense LLC (ISL) at the 2016 AUSA Annual Meeting and Exposition (booth# 225). The AUSA Annual Meeting will be from October 3-5 2016 at Washington D.C. The AUSA is one of the largest land warfare expositions and professional development forums in the world and presents a unique opportunity to learn about ISL's technology from the R&D staff. The ISL exhibition will feature the following technologies: Therm-E-Log, FogGo, Trap&See and HypergoLeak. Stop by the exhibition (booth #225) to see samples, experience the technology firsthand and learn more.
If you are attending the 2016 AUSA Meeting and are interested in any of our technologies and would like to meet us there, please contact us at firstname.lastname@example.org
ICM's The Climber, a remote-controlled robot that can scale virtually any vertical or inverted surface, spray coated ISL's Trap & See-Hg on dry wall, cement and aluminum surfaces. Videos and photos of the Climber's spray coating and peeling Trap & See-Hg coatings can be viewed in detail under Trap & See's description.
In "The Heat is On" Corrie Pelc reviews the future of flame-retardant textile protection including InnoSense's FirePhob - a family of nontoxic, non-halogenated, flame retardant materials. The article review was published in the American Association of Textile Chemists and Colorist for the November/December 2015, Vol. 15, No. 6 issue.
Pelc's thesis is that fire retardants are one of the textile treatments which have a significant impact - protecting and saving lives. ISL's FirePhob flame retardant materials are featured here as an example of a novel effective, breathable, nontoxic FR treatment, but also of one which has the potential to reach a wider end user market. As FR treatments, such as FirePhob, become safer, cost-effective and long lasting, FR treated textiles could become a standard feature in more textiles.
The United States Patent and Trademark Office (USPTO) has issued a patent for Therm-E-Log on March 17 (United States Patent no. 8,979,361) to ISL. Therm-E-Log is a customizable time-temperature dosimeter, full claims and description can be found at the USPTO's full-text and image patent webpage.
Therm-E-Log was developed using government support under contract number W15QKN-09-C-0153, awarded by the U.S. Army Joint Munitions & Lethality (JML) Contracting Center. Therm-E-Log has been under development for use by the Army to monitor the temperature exposure of ammunition thus, also ensuring ammunition quality and personnel safety. Prospects for the wider use of Therm-E-Log by DoD agencies is high for in addition to the issued patent, Therm-E-Log field trials are also underway.
To find out more about Therm-E-Log and the technology behind it, visit our Therm-E-Log description webpage.
The Department of Energy has awarded ISL a Phase II contract for the work titled "Thermo-Mechanically Stable Tungsten Powders as Solid Catchers for the Fast Release of Stopped Rare Isotopes." This project is a continuation of the Phase I contract of the same name.